Cutler Group’s CapForce IBD 50 ETF FFTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-7,300
Closed -$31K 5007
2020
Q3
$31K Buy
7,300
+4,900
+204% +$181K ﹤0.01% 2130
2020
Q2
$13K Buy
+2,400
New +$74.6K ﹤0.01% 2675
2020
Q1
Sell
-6,300
Closed -$5K 4193
2019
Q4
$5K Buy
+6,300
New +$213K ﹤0.01% 3029
2019
Q2
Sell
-800
Closed -$7K 4409
2019
Q1
$7K Sell
800
-3,100
-79% -$97.6K ﹤0.01% 2713
2018
Q4
$1K Buy
+3,900
New +$121K ﹤0.01% 3606

Other funds holding FFTY

Cutler Group's FFTY Position: Q1 2024 in Review

Cutler Group sold out of CapForce IBD 50 ETF (FFTY) in Q1 2024, closing a stake of 869 shares — an estimated $22.7K sold.

Cutler Group first reported a position in FFTY in Q2 2018 and held it in 15 quarters. The position peaked at $254K in Q4 2020. 40 funds tracked by Wall St. Rank hold FFTY as of Q1 2024.

  • Cutler Group reported no remaining CapForce IBD 50 ETF position as of Q1 2024 after selling out during the quarter.
  • Cutler Group sold 869 CapForce IBD 50 ETF shares in Q1 2024, an estimated $22.7K.
  • Cutler Group first reported a position in CapForce IBD 50 ETF in Q2 2018 and held it in 15 quarters.
  • Cutler Group's CapForce IBD 50 ETF position peaked at $254K in Q4 2020.
  • 40 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.